06.28.24 -- Where's The Case For Generative AI In Biopharmaceutical Manufacturing?

Realize the value of connectivity, and more specifically, the value of the information provided by checkweighing, metal detection, vision inspection, and x-ray inspection.

Industry experts weigh in on how to help 503(b) compounding facilities bring acute care drugs to market more quickly, provide a safer drug administration process, and minimize health care and hospital costs.

Learn in detail about high voltage leak detection (HVLD), packaging applications that can be inspected with HVLD, and how to determine the best leak-testing method for your application.

Combined with the inherent difficulty of the chemistry behind gene therapy development, its pace, structure, and funding dynamics are unique among treatment modalities.

Antibody-drug conjugates' manufacturing supply chain contains five different technologies with specific asset needs: monoclonal antibody, cytotoxic payload, linker, bioconjugation, and fill/finish.

A partner with state-of-the-art facilities can guarantee efficient and scalable production of ophthalmic solutions, drops, and ointments, and is critical as you navigate the complexities of ophthalmic production.

Explore factors to consider as your organization works to conform to the serialization guidelines.

Leveraging the expertise of a chosen clinical supply partner can be a valuable resource. Examine key considerations when partnering with a CRO in order to deliver a successful clinical supply strategy.

To achieve a successful inspection, organizations should adopt best practices. Examine these eight invaluable tools for inspection success.

If the lyophilization process is applied to a single droplet of liquid, it creates a lyo ‘bead’ rather than a lyo 'cake.' Discover the potential of lyobeads and why they are an excellent alternative.

Partnering with a CDMO that offers comprehensive and robust E&L studies can help facilitate a smooth product launch by ensuring minimal impact from impurities, all while mitigating risks.

A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.

By reducing the size of drug particles, nanoforming can open up new opportunities — from increasing bioavailability to enabling sustained drug delivery. Discover the potential benefits supported by case studies.

As demand for more precise, tailored CRO services grows, so does the emphasis drug developers place on their partners’ flexibility, agility, and enthusiasm for collaboration.

Finding the right mixing equipment isn’t as simple as selecting an item from a menu. Here is what you should consider when choosing pharmaceutical mixing equipment and vendors for a facility.